Pharmacovigilance Videos & Webinars

VIDEOS

Pharmacovigilance, explained by the people who do it

Physician-led conversations on the decisions, dilemmas, and future of drug safety. Whether you're building a PV system from scratch or scaling a global operation, our experts speak plainly about what works, what doesn't, and what's coming next.

The Future of PV: AI, People, and the Human Edge

As AI capabilities expand, one question keeps coming up in pharmacovigilance: what happens to your role?

The PV AI Question Nobody Can Answer Yet

AI is already in pharmacovigilance. It's not a pilot, it's not a conversation, it's happening. So what does that actually mean for the industry? Jan Petracek sets the scene.

How Drug Safety Decisions are Made in the Real World

In pharmacovigilance, decisions are rarely made with perfect data, unlimited time, or complete certainty.

In this series, we speak directly to you about how safety decisions are actually made in real-world PV environments. Not in theory, and not by checklist, but through judgment, context, and experience. Drawing on decades of work across pharma, CROs, inspections, and global PV operations, we look at the practical trade-offs you navigate every day and the reasoning that sits behind them.

This series is about recognizing the decisions you already make, understanding why they’re complex, and thinking more clearly about what truly shapes safety outcomes in practice.

Pharmacovigilance Oursourcing Truths

Outsourcing pharmacovigilance is one of the most consequential decisions you'll make for your drug safety program, and most people get at least part of it wrong. In this four-part series, Henry Seto and Jan Petracek have an honest conversation about what PV outsourcing actually looks like, what history has taught us, and what you need to know before you sign anything.

Before You Sign with a PV Vendor, Watch This

If you’re weighing whether to build pharmacovigilance internally or outsource it, the decision is rarely as simple as it first appears.

In this video, we examine why this question keeps coming up, what’s often overlooked on both sides, and how responsibility, oversight, and operational reality shape the outcome more than the model itself.

This episode helps you step back and think more clearly about what this decision really means for your PV system before you commit either way.

Making Sense of Argus Before You Make a Decision

If you’re evaluating a safety database or the partners who support it, you’ve likely noticed how confident the conversations sound, and how unclear the answers can still feel. This series focuses on the questions buyers regularly ask but don’t always get clear answers to. Each episode looks at one of those questions, using real conversations to add context, not to tell you what to choose, but to help you understand what you’re actually deciding.

FAQ

answer

FAQ

Answer

FAQ

Answer

FAQ

Answer

LET'S TALK

Put Your Question to a Pharmacovigilance Expert

Tell us what you're working on, whatever the stage or market. We'll make sure your question reaches the specialist who leads that area, and that you get a real, considered answer back, not a brochure.

Actual iVigeeans ↑

Does It Really Matter if My PV Vendor Is Physician-Led?

Before you compare vendors or talk about outsourcing, you need to understand what great pharmacovigilance leadership really looks like. Dr. Henry Seto answers the question directly, and honestly. Press play to hear what most vendors won't tell you. ↓

More pharmacovigilance insights from people who live it.

From physician-led videos to practical guides and regulatory updates, everything in our Knowledge Hub is designed to help you make confident, informed decisions.

Start learning